Chapter 4: Hemodynamic Disorders,

Thromboembolism, and Shock

1. Hyperemia and Congestion

Hyperemia and congestion are conditions related to abnormal blood volumes

within tissues, but they arise from different mechanisms.

• Hyperemia is an active process characterized by increased blood

flow to tissues. It occurs due to arteriolar dilation, commonly seen in cases of
inflammation or in tissues during exercise. The increased oxygenated blood flow
results in a reddish appearance of the affected tissue, as observed in erythema.
• Congestion, in contrast, is a passive process resulting from
impaired venous outflow. This leads to a buildup of deoxygenated blood, giving
the tissue a bluish hue, known as cyanosis. Congestion often occurs in
conditions like cardiac failure or local venous obstruction.

Morphological Features:

• Acute Pulmonary Congestion: The alveolar capillaries become

engorged, leading to alveolar septal edema and intra-alveolar hemorrhage.
• Chronic Pulmonary Congestion: Prolonged congestion results in
fibrosis of the alveolar septa and the presence of hemosiderin-laden
macrophages, also known as “heart failure cells.”
• Acute Hepatic Congestion: Central veins and sinusoids become
distended with blood, leading to central hepatocyte necrosis. Peripheral
hepatocytes may undergo fatty changes due to relatively lesser hypoxia.
• Chronic Hepatic Congestion: Seen in right heart failure, it results
in a characteristic “nutmeg liver” appearance. Central regions of hepatic lobules
become red-brown due to cell loss and necrosis, while the peripheral regions
remain relatively normal.

2. Edema

1
Edema is defined as the accumulation of excess fluid in interstitial spaces within
tissues, while effusions refer to the accumulation of fluid within body cavities.
● Types of Edema:
• Localized Edema: Occurs in specific organs or tissues, such as in
cerebral or pulmonary edema.
• Generalized Edema (Anasarca): Severe form of systemic edema
affecting the entire body, often associated with systemic disorders like nephrotic
syndrome or severe heart failure.

Causes of Edema:

1. Increased Hydrostatic Pressure:

• Seen in congestive heart failure, where impaired venous return leads
to increased capillary pressure, pushing fluid out into the interstitium.
• Local venous obstruction, such as in deep vein thrombosis (DVT),
can also elevate local hydrostatic pressure, causing edema in the affected limb.
2. Decreased Plasma Oncotic Pressure:
• Caused by low levels of plasma proteins, especially albumin, which
normally maintain osmotic balance.
• Conditions like nephrotic syndrome (protein loss through urine), liver
cirrhosis (reduced protein synthesis), and severe malnutrition lead to
hypoproteinemia, resulting in reduced oncotic pressure and fluid shift into
tissues.
3. Lymphatic Obstruction:
• Lymphatic drainage plays a critical role in returning interstitial fluid to
the circulation. Blockage of lymphatic vessels due to tumors, surgical removal of
lymph nodes, or infections like filariasis results in lymphedema.
• In breast cancer patients, lymphatic obstruction around the nipple
leads to peau d’orange (orange peel appearance).
4. Sodium and Water Retention:
• Increased salt retention leads to water retention, which enhances
hydrostatic pressure and reduces oncotic pressure.
• Renal diseases, such as acute renal failure or glomerulonephritis,
can trigger this mechanism, often through activation of the
renin-angiotensin-aldosterone system (RAAS).

2
 5. Inflammation:
• Inflammatory conditions increase vascular permeability, allowing
fluid and proteins to leak into tissues, leading to inflammatory edema.
• Chronic inflammation and processes like angiogenesis also
contribute to localized edema formation.

Morphological Features and Clinical Presentations:

● Subcutaneous Edema:
• Manifests in body parts dependent on gravity, such as the legs (in
standing individuals) or the sacrum (in bedridden patients).
● Pitting edema occurs when pressure applied to the swollen area leaves a
depression.
● Pulmonary Edema:
• The lungs become heavy, and frothy fluid may fill the alveoli,
impairing gas exchange. Causes include left ventricular failure, renal failure, and
acute respiratory distress syndrome (ARDS).
● Cerebral Edema:
• The brain tissue swells, narrowing the sulci and flattening the gyri.
Severe cases can result in herniation through the foramen magnum,
compressing the brainstem and leading to fatal outcomes.

3. Hemorrhage

Hemorrhage refers to the escape of blood from the vascular compartment due to
vessel rupture or abnormal clotting.

● Types of Hemorrhage:
1. Hematoma: A localized collection of blood within a tissue or organ,
ranging from minor bruises to large accumulations, such as a retroperitoneal
hematoma.
2. Petechiae: Tiny pinpoint hemorrhages on skin or mucous
membranes, often resulting from low platelet counts or defective platelet function.
3. Purpura: Larger than petechiae, caused by similar mechanisms but
may also be due to trauma or increased vascular fragility.

3
 4. Ecchymoses: Subcutaneous hemorrhages (bruises) that undergo
characteristic color changes as the hemoglobin is degraded into bilirubin and
hemosiderin.

Clinical Implications:

• Rapid blood loss of up to 20% of total blood volume can lead to

hypovolemic shock. Chronic external blood loss, such as gastrointestinal
bleeding, can result in iron deficiency anemia.

4. Hemostasis and Coagulation

Hemostasis is the physiological process that prevents and stops bleeding

through the formation of a stable blood clot at the site of vascular injury.

Phases of Hemostasis:

1. Arteriolar Vasoconstriction:
• Immediate response mediated by endothelin, reducing blood flow to
the injured site.
2. Primary Hemostasis (Platelet Plug Formation):
• Platelets adhere to exposed subendothelial collagen via von
Willebrand factor (vWF).
• Platelet activation and secretion of procoagulant factors like
thromboxane A2 (TXA2) promote aggregation.
3. Secondary Hemostasis (Coagulation Cascade):
• Tissue factor (TF) from damaged endothelium activates the
coagulation cascade, leading to thrombin generation.
• Thrombin converts fibrinogen to fibrin, stabilizing the platelet plug.
4. Clot Stabilization and Resorption:
• The clot is consolidated and then gradually resorbed by fibrinolytic
mechanisms, restoring vessel patency.

5. Thrombosis

4
Thrombosis refers to the pathological formation of a blood clot (thrombus) within
intact vessels or the heart, leading to potential obstruction of blood flow. It plays a
central role in many cardiovascular and cerebrovascular diseases.

Virchow’s Triad

The three primary factors contributing to thrombosis, collectively known as

Virchow’s Triad, include:

1. Endothelial Injury:
• Endothelial damage is a dominant factor in the development of
thrombi, especially in arteries and the heart. Exposed subendothelial matrix,
collagen, and vWF activate platelets and initiate thrombus formation.
• Causes include physical injury, inflammatory mediators, turbulent
blood flow, and toxins like cigarette smoke.
2. Abnormal Blood Flow:
• Turbulence disrupts laminar blood flow, bringing platelets into
contact with the endothelium and promoting endothelial injury.
• Stasis allows activated clotting factors to accumulate and inhibits the
dilution of clotting inhibitors.
• Conditions such as aneurysms, acute myocardial infarctions, and
hyperviscosity syndromes (e.g., polycythemia vera) predispose to abnormal
blood flow.
3. Hypercoagulability:
• Defined as an increased tendency of the blood to clot due to
alterations in the coagulation pathways.
• It may be primary (genetic), such as factor V Leiden mutation or
prothrombin gene mutation, or secondary (acquired), such as in prolonged bed
rest, cancer, or antiphospholipid antibody syndrome.

Morphological Types of Thrombi

• Arterial Thrombi: Typically form at sites of endothelial injury or

turbulence (e.g., atherosclerotic plaques). They are rich in platelets, making
antiplatelet therapies effective.

5
 • Venous Thrombi: Form in areas of stasis, such as the deep veins of
the legs. Known as red thrombi due to their high RBC content, they often lead to
complications like pulmonary embolism.
• Mural Thrombi: Occur in large vessels like the aorta or the heart
chambers, often due to abnormal cardiac motion (e.g., atrial fibrillation) or
endothelial injury.
• Heart Valve Thrombi (Vegetations): Arise from infective
endocarditis or nonbacterial thrombotic endocarditis, resulting in vegetations on
the heart valves.

Fate of the Thrombus

1. Propagation: The thrombus enlarges through the accumulation of

additional platelets and fibrin, leading to vessel obstruction.
2. Embolization: A fragment of the thrombus dislodges and travels to
a distant site, causing vessel occlusion (e.g., pulmonary embolism).
3. Dissolution: Fibrinolytic mechanisms reduce the size of the
thrombus. Recent thrombi respond better to fibrinolysis, while older thrombi are
resistant due to fibrin cross-linking.
4. Organization and Recanalization: The thrombus is incorporated
into the vessel wall through the ingrowth of endothelial cells, smooth muscle
cells, and fibroblasts. Small vascular channels may form, restoring blood flow.

Clinical Consequences of Thrombosis

• Arterial Thrombi: Can lead to downstream ischemia and infarction

in organs such as the heart (myocardial infarction), brain (ischemic stroke), or
extremities.
• Venous Thrombi: Often associated with pain and swelling in the
affected limb. A significant risk is the potential for pulmonary embolism,
particularly from deep vein thrombosis (DVT).

6. Embolism

An embolism refers to the movement of an intravascular solid, liquid, or gas

mass through the bloodstream, which can cause vessel occlusion and

6
subsequent tissue ischemia or infarction. The most common form is a
thromboembolism, originating from a dislodged thrombus.

Types of Emboli

1. Pulmonary Embolism (PE):

• Source: 95% of pulmonary emboli originate from deep vein thrombi
(DVT) in the legs, typically above the knee.
• Pathophysiology: The embolus travels through the venous
circulation to the right heart, eventually lodging in the pulmonary arteries.
Depending on its size, it can cause a range of effects from asymptomatic small
emboli to sudden death (e.g., saddle embolus blocking the main pulmonary
artery).
• Clinical Outcomes:
• Small Emboli: May be asymptomatic but increase the risk of
recurrent embolism and pulmonary hypertension.
• Large Emboli: May obstruct major pulmonary arteries, leading to
sudden death.
• Medium-Sized Emboli: Can cause pulmonary hemorrhage or
infarction, especially in patients with left heart failure.
2. Systemic Embolism:
• Source: 80% originate from left-sided cardiac mural thrombi (e.g.,
following a myocardial infarction). They can also arise from aortic aneurysms or
ulcerated atherosclerotic plaques.
• Target Organs: Systemic emboli often affect organs with high blood
flow, such as the lower extremities, brain, and kidneys.
• Clinical Consequences: Arterial emboli can cause ischemia and
infarction in the affected organs, leading to significant morbidity or mortality
depending on the location.
3. Fat Embolism:
• Source: Typically occurs following long bone fractures or soft tissue
trauma, releasing fat globules into the bloodstream.
• Pathophysiology: Fat emboli can travel to the lungs and brain,
obstructing small capillaries and triggering a systemic inflammatory response.

7
 • Clinical Manifestations: Fat embolism syndrome (FES) presents
with pulmonary distress, neurological symptoms, petechial rash, and
thrombocytopenia.
4. Amniotic Fluid Embolism:
• Source: Entry of amniotic fluid into maternal circulation during labor
or postpartum period due to tears in the placental membranes or uterine veins.
• Pathophysiology: The foreign material triggers a systemic
inflammatory response, activating coagulation and causing widespread
microthrombi formation.
• Clinical Manifestations: Sudden onset of dyspnea, hypotensive
shock, seizures, and disseminated intravascular coagulation (DIC). It is a major
cause of maternal mortality.
5. Air Embolism:
• Source: Gas bubbles enter the circulation, typically due to iatrogenic
causes (e.g., surgery), trauma, or decompression sickness.
• Pathophysiology: Air bubbles can obstruct vessels, causing
ischemia. In decompression sickness (“the bends”), nitrogen bubbles form in
blood and tissues due to rapid pressure changes.
• Clinical Consequences: Small air emboli can obstruct the
pulmonary vasculature, while larger emboli can cause cardiovascular collapse.

7. Infarction

Infarction refers to an area of ischemic necrosis resulting from the occlusion of

the vascular supply to a tissue. Infarctions are commonly caused by arterial
thrombosis or embolism but can also occur due to venous obstruction, trauma, or
vasospasm. The outcome depends on several factors, including the type of
vascular supply, the rate of occlusion, and the vulnerability of the tissue to
hypoxia.

Causes of Infarction

• Arterial Occlusions: The most common cause of infarctions. This

can result from thrombosis, embolism, vasospasm, or extrinsic compression of a
vessel.

8
 • Venous Occlusions: Typically less common, as venous blockages
often result in congestion rather than infarction. Venous infarction can occur if
there is a single outflow channel, such as in testicular or ovarian torsion.

Morphological Classification of Infarcts

Infarcts can be classified based on their appearance and blood content:

1. Red (Hemorrhagic) Infarcts:

• Occur in tissues with a dual blood supply (e.g., lungs, small
intestine) or in loose tissues (e.g., lungs) where blood can accumulate.
• Typically seen in venous occlusions or when blood re-enters a
previously ischemic tissue.
• The infarcted area appears dark red and congested.
2. White (Anemic) Infarcts:
• Occur in solid organs (e.g., heart, spleen, kidney) with a single blood
supply.
• The tissue becomes pale and sharply demarcated due to the lack of
blood flow.
• Typically seen with arterial occlusions in end-artery organs.
3. Septic Infarcts:
• Develop when infected emboli or microbes seed an area of necrosis.
• These infarcts can progress to abscess formation and are often
complicated by a severe inflammatory response.

Morphology and Histological Changes in Infarcts

• Macroscopic Appearance: Infarcts are typically wedge-shaped,

with the occluded vessel at the apex and the periphery of the affected organ at
the base.
• Histological Features: Most infarcts present with ischemic
coagulative necrosis, except in the brain, where liquefactive necrosis occurs. The
necrotic tissue is eventually replaced by a scar through fibrosis.
• Healing: Infarcts in the heart and kidney often heal by scarring,
while cerebral infarcts lead to cystic spaces due to the dissolution of necrotic
tissue.

9
Factors Affecting the Development of Infarcts

1. Nature of the Vascular Supply: Organs with a dual blood supply

(e.g., lungs and liver) are less susceptible to infarction. Organs with a single
blood supply (e.g., kidneys and spleen) have a higher risk.
2. Rate of Occlusion: Slow-developing occlusions allow time for
collateral circulation to develop, reducing the likelihood of infarction.
3. Tissue Susceptibility to Ischemia: Tissues such as neurons and
myocardial cells are highly sensitive to hypoxia and can undergo irreversible
damage within minutes. Fibroblasts, in contrast, can tolerate hypoxia for several
hours.
4. Oxygen Content of Blood: Hypoxemia (low blood oxygen levels)
increases the risk and severity of infarctions, even with partial vessel occlusion.

8. Shock

Shock is a state of systemic hypoperfusion resulting from a significant reduction

in either cardiac output or circulating blood volume. The resultant inadequate
tissue perfusion leads to cellular hypoxia, which, if uncorrected, can cause
irreversible cellular and organ damage, ultimately leading to death.

Types of Shock

1. Cardiogenic Shock:
• Caused by a failure of the heart to pump blood effectively, leading to
decreased cardiac output.
• Etiologies: Myocardial infarction, ventricular rupture, arrhythmias,
cardiac tamponade, or massive pulmonary embolism.
• Pathophysiology: Impaired myocardial function leads to reduced
tissue perfusion, pulmonary congestion, and systemic hypotension.
2. Hypovolemic Shock:
• Results from a significant loss of blood or plasma volume, reducing
venous return and, consequently, cardiac output.
• Etiologies: Hemorrhage, severe burns, dehydration, or trauma.

10
 • Pathophysiology: Decreased intravascular volume results in
inadequate perfusion of vital organs.
3. Septic Shock:
• Arises from a systemic inflammatory response to severe infections,
especially by Gram-positive and Gram-negative bacteria and fungi.
• Pathophysiology: Inflammatory mediators (e.g., cytokines) cause
systemic vasodilation, increased vascular permeability, and microvascular
thrombosis, leading to hypotension, organ dysfunction, and disseminated
Tumor necosis factor alpha interluikins 1,6,8 , anti-inflamatory
intravascular coagulation (DIC).
cytokines 10,4 , prostaglandins , platelets activating factors , high
4. Neurogenic Shock: mobility group box 1 protein and bradykinin
• Caused by a sudden loss of vascular tone due to spinal cord injury
or anesthesia.
• Pathophysiology: Loss of sympathetic vascular tone results in
widespread vasodilation and pooling of blood, reducing effective circulating
volume.
5. Anaphylactic Shock:
• An IgE-mediated hypersensitivity reaction triggered by allergens
(e.g., drugs, insect stings, foods).
• Pathophysiology: Widespread vasodilation and increased vascular
permeability result in fluid loss from the vasculature and severe hypotension.

Pathogenesis of Septic Shock

Septic shock is a severe manifestation of sepsis, caused by the systemic effects

of bacterial endotoxins or other microbial products. It involves the following
mechanisms:

• Inflammatory Response: Microbial components such as

lipopolysaccharides (LPS) activate Toll-like receptors (TLRs) on immune cells,
triggering the release of pro-inflammatory cytokines like TNF and IL-1.
• Endothelial Activation and Injury: Activated endothelium
increases vascular permeability and expresses pro-coagulant factors,
contributing to DIC and tissue ischemia.
• Metabolic Abnormalities: Insulin resistance and hyperglycemia are
common, as cytokines impair glucose metabolism. Lactic acidosis can result from
anaerobic glycolysis.

11
 • Immunosuppression: Prolonged sepsis can lead to an
immunosuppressive state due to the release of anti-inflammatory cytokines like
IL-10.

Stages of Shock

Shock progresses through three stages:

1. Non-Progressive Stage:
• Initial compensatory mechanisms maintain vital organ perfusion
through baroreceptor reflexes, catecholamine release, and activation of the
RAAS.
• Clinical Signs: Tachycardia, peripheral vasoconstriction, and fluid
retention. The skin appears cool and clammy (except in septic shock, where it is
warm and flushed).
2. Progressive Stage:
• Compensatory mechanisms begin to fail, leading to tissue
hypoperfusion, lactic acidosis, and endothelial dysfunction.
• Clinical Signs: Widespread hypoxia causes cellular injury,
decreased cardiac output, and risk of disseminated intravascular coagulation
(DIC).
3. Irreversible Stage:
• Severe cellular and organ damage is irreversible, even if
hemodynamic stability is restored.
• Clinical Signs: Multiorgan failure, severe hypotension, and coma.
The patient progresses to death due to widespread cellular necrosis.

Morphological Changes in Shock

• Brain: Ischemic encephalopathy with watershed infarcts.

• Heart: Coagulative necrosis of myocardial cells.
• Kidneys: Acute tubular necrosis, leading to renal failure.
• Lungs: Shock lung, characterized by diffuse alveolar damage
(except in hypovolemic shock).
• Gastrointestinal Tract: Mucosal hemorrhage and necrosis, leading
to stress ulcers.

12
 ○ .

13